Review: Testosterone therapy for reduced libido in women

Therapeutic Advances in Endocrinology and Metabolism

Volumn 1, Issue 4, 2010, Pages 155-164

  Basson, Rosemary ^a  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

libido; sexual dysfunction; testosterone; women's sexual desire

Indexed keywords

ANDROGEN RECEPTOR; ESTRADIOL; ESTROGEN; NORETHISTERONE ACETATE; PLACEBO; PRASTERONE; TESTOSTERONE; TIBOLONE;

ANDROGEN THERAPY; ARTICLE; BREAST CANCER; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ESTROGEN DEFICIENCY; FEMALE SEXUAL DYSFUNCTION; HIGH RISK POPULATION; HORMONE ACTION; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; HYSTERECTOMY; LIBIDO DISORDER; LONG TERM CARE; MOTIVATION; OFF LABEL DRUG USE; PATIENT SELECTION; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN FUNCTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEPTOR SENSITIVITY; RISK BENEFIT ANALYSIS; SALPINGOOOPHORECTOMY; SEXUAL AROUSAL; SEXUAL SATISFACTION; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE SYNTHESIS; TREATMENT DURATION; VAGINA ATROPHY; WOMEN'S HEALTH;

EID: 79952828628     PISSN: 20420188     EISSN: None     Source Type: Journal    
DOI: 10.1177/2042018810379588     Document Type: Review

References (63)

1. Arlt, W. ( 2006) Androgen therapy in women. Eur J Endocrinol 154: 1-11.
2. Avis, N.E., Zhao, X., Johannes, C.B., Ory, M., Brockwell, S. and Greendale, G.A. ( 2005) Correlates of sexual function among multi ethnic middle aged women: Results from the study of Women's health across the nation (SWAN). Menopause 12: 385-398.
3. Aziz, A., Brannstrom, M., Bergquist, C. and Silfverstople, G. ( 2005) Perimenopausal androgen decline after oophorectomy does not influence sexuality or psychological well-being. Fertil Steril 83: 1021-1028.
4. Bancroft, J., Loftus, J. and Long, J.S. ( 2003) Distress about sex: A national survey of women in heterosexual relationships. Arch Sex Behav 32: 193-211.
5. Barton, D.L., Wender, D.B., Sloan, J.A., Dalton, R.J., Balcueva, E.P., Atherton, P.J. et al (2007) Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido: North Central Cancer Treatment Group Protocol N02C3. J Natl Cancer Inst 99: 672-679.
6. Basson, R. ( 2001) Female sexual response: The role of drugs in the management of sexual dysfunction. Obstet Gynecol 98: 350-352.
7. Basson, R. ( 2000) The female sexual response: A different model. J Sex Marital Ther 26: 51-65.
8. Basson, R. ( 2006) Clinical practice: Sexual desire and arousal disorders in women. New Engl J Med 354: 1467-1506.
9. Basson, R., Brotto, L.A., Petkau, J. and Labrie, F. ( 2010) Role of androgens in Women's sexual dysfunction. Menopause, DOI: 10.1097/gme.0b013e3181d59765.
10. Basson, R., Rees, P., Wang, R., Montejo, A.L. and Incrocci, L. (2010) Sexual function in chronic illness. J Sex Med 7: 374-388.
11. Bitzer, J., Kenemans, P. and Mueck, A.O. ( 2008) Breast cancer risk in postmenopausal women using testosterone in combination with hormone replacement therapy. Maturitas 59: 209-218.
12. Bozman, A.W. and Beck, J.G. ( 1991) Covariation of sexual desire and sexual arousal: The effects of anger and anxiety. Arch Sex Behav 20: 47-60.
13. Brand, J.S. and van der Schouw, Y.T. (2010) Testosterone, SHBG and cardiovascular health in postmenopausal women. Int J Impot Res 22: 91-104.
14. Braunstein, G., Sundwall, D.A., Katz, M., Shifren, J.L., Buster, J.E., Simon, J.A. et al (2005) Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual disorder in surgically menopausal women: A randomized, placebo-controlled trial. Arch Intern Med 165: 1582-1589.
15. Brotto, L.A. ( 2010) The DSM diagnostic criteria for hypoactive sexual desire disorder in women. Arch Sex Behav 39: 221-239.
16. Brotto, L.A., Heiman, J.R. and Tolman, D. (2009) Narratives of desire in mid-age women with and without arousal difficulties. J Sex Res 46: 387-398.
17. Buster, J.E., Kingsberg, S.A., Aguirre, O., Brown, C., Breaux, J.G., Buch, A. et al (2005) Testosterone patch for low sexual desire in surgically menopausal women: A randomized trial. Obstet Gynecol 105: 944-952.
18. Cain, V.S., Johannes, C.B., Avis, N.E., Mohr, B., Schocken, M., Skurnick, J. et al (2003) Sexual functioning and practices in a multi-ethnic study of midlife women: Baseline results from SWAN. J Sex Res 40: 266-276.
19. Chivers, M.L., Seto, M.C., Lalumière, M.L., Laan, E. and Grimbos, T. (2010) Agreement of self-reported and genital measures of sexual arousal in men and women: A meta-analysis. Arch Sex Behav 39: 5-56.
20. Clayton, A., Kornstein, S., Prakash, A., Mallinckrodt, C. and Wohlreich, M. ( 2007) Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med 4: 917-929.
21. Davis, S., Moreau, M., Kroll, R., Bouchard, C., Panay, N., Gass, M. et al (2008 a) Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 359: 2005-2017.
22. Davis, S., Papalia, M.A., Norman, R.J., O'Neill, S., Redelman, M., Williamson, M. et al (2008 b) Safety and efficacy of a testosterone metered-dose transdermal spray for treatment of decreased sexual satisfaction in premenopausal women: A placebo-controlled randomized, dose ranging study. Ann Intern Med 148: 569-577.
23. Davis, S.R., Davison, S.L., Donath, S. and Bell, R.J. ( 2005) Circulating androgen levels in self-reported sexual function in women. JAMA 294: 91-96.
24. Davis, S.R., Nijland, F.A. and Weijmar-Schultz, W. ( 2006a) Tibolone vs. transdermal continuous combined estrogen plus progestin in the treatment of female sexual dysfunction in naturally menopausal women: Results from the NETA trial. Maturitas 554(Suppl): S1-S112.
25. Davis, S.R., van der Mooren, M.J., van Lunsen, R.H.W., Lopes, P., Ribot, C., Rees, M. et al (2006 b) Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: A randomized, placebo controlled-trial. Menopause 13: 387-396.
26. Davison, S.L., Bell, R., Donath, S., Montalto, J.G. and Davis, S.R. ( 2005) Androgen levels in adult females: Changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 90: 3847-3853.
27. Dennerstein, L., Dudley, E. and Burger, H. ( 2001) Are changes in sexual functioning during mid-life due to aging or menopause? Fertil Steril 76: 456-460.
28. Dennerstein, L., Koochaki, P., Barton, I. and Graziottin, A. ( 2006) Hypoactive sexual desire disorder in menopausal women: A survey of western European women. J Sex Med 3: 212-222.
29. DBT T. (2009) Testosterone patches for female sexual dysfunction. Drug Ther Bull 47: 30-34.
30. Farquhar, C.M., Harvey, S.A., Yu, Y., Sadler, L. and Stewart, A.W. ( 2006) A prospective study of three years of outcomes after hysterectomy with and without oophorectomy. Am J Obstet Gynecol 194: 711-717.
31. Goldstat, R., Briganti, E., Tran, J., Wolfe, R. and Davis, S.R. ( 2003) Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause 10: 390-398.
32. Graham, C.A. ( 2010) The DSM diagnostic criteria for female sexual arousal disorder. Arch Sex Behav 39: 240-255.
33. Hartmann, U., Philippsohn, S., Heiser, K. and Rüffer-Hesse, C. ( 2004) Low desire in midlife and older women: Personality factors, psychosocial development, present sexuality. Menopause 11: 726-740.
34. Hayes, R.D. ( 2008) Assessing female sexual dysfunction in epidemiological studies: Why is it necessary to measure both low sexual function and sexually related distress? Sex Health 5: 215-218.
35. Ishunina, T.A. and Swaab, D.F. ( 2007) Alterations in the human brain in menopause. Maturitas 57: 20-22.
36. Janssen, E., Everaerd, W., Spiering, M. and Janssen, J. ( 2000) Automatic processes and the appraisal of sexual stimuli: Toward an information processing model of sexual arousal. J Sex Res 37: 8-23.
37. Kennedy, S.H., Dickens, S.C., Eisfeld, B.S. and Bagby, R.M. ( 1999) Sexual dysfunction before antidepressant therapy in major depression. J Affect Disord 56: 201-208.
38. Kingsberg, S., Shifren, J., Wekselman, K., Rodenberg, C., Koochaki, P. and DeRogatis, L. ( 2007) The evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder. J Sex Med 4: 1001-1008.
39. Klusmann, D. ( 2002) Sexual motivation and the duration of partnership. Arch Sex Behav 31: 275-287.
40. Labrie, F., Archer, D., Bouchard, C., Fortier, M., Cusan, L., Gomez, J.L. et al (2009) Effect on intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause 16: 923-931.
41. Labrie, F., Bélanger, A., Tusan, L., Cusan, L. and Candas, B. ( 1997) Marked decline in serum concentrations of adrenal C 19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 82: 2396-2402.
42. Leiblum, S.R., Koochaki, P.E., Rodenberg, C.A., Barton, I.P. and Rosen, R.C. ( 2006) Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause 13: 46-56.
43. Li, J. and Al-Azzawi, F. (2009) Mechanism of androgen receptor action. Maturitas 63: 142-148.
44. Lutfey, K.E., Link, C.L., Rosen, R.C., Wiegel, M. and McKinlay, J.B. (2009) Prevalence and correlates of sexual activity and function in women: Results from the Boston Area Community Health (BACH) Survey. Arch Sex Behav 38: 514-527.
45. McCall, K. and Meston, C. ( 2007) Differences between pre- and postmenopausal women in cues for sexual desire. J Sex Med 4: 364-371.
46. Melcangi, R.C., Garcia-Segura, L.M. and Mensah-Nygan, A.G. ( 2008) Neuroactive steroids: State of the art and new perspectives. Cell Mol Life Sci 65: 777-797.
47. Meston, C.M. and Buss, D.M. ( 2007) Why humans have sex. Arch Sex Behav 36: 477-507.
48. Nachtigall, L., Casson, P., Lucas, J., Melson, C. and Schofield, V. ( 2006) Safety and tolerability of transdermal testosterone systems (TTS) in surgically menopausal women receiving oral or transdermal estrogen over 36-months of therapy. Menopause 13: 1022.
49. Panay, N., Al-Azzawi, F., Bouchard, C., Davis, S.R., Eden, J., Lodhi, I. et al (2010) Testosterone treatment of HSDD in naturally menopausal women: The ADORE study. Climacteric 13: 121-131.
50. Sanders, S.A., Graham, C.A. and Milhausen, R.R. ( 2008) Predicting sexual problems in women: The relevance of sexual excitation and sexual inhibition. Arch Sex Behav 38: 241-251.
51. Santoro, N., Torrens, J., Crawford, S., Allsworth, J.E., Finkelstein, J.S., Gold, E.B. et al (2005) Correlates of circulating androgens in midlife women: The study of Women's health across the nation. J Clin Endocrinol Metab 90: 4836-4845.
52. Shifren, J.L., Davis, S.R., Moreau, M., Waldbaum, A., Bouchard, C., DeRogatis, L. et al (2006) Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: Results from the INTIMATE NM 1 STUDY. Menopause 13: 770-779.
53. Simon, J., Braunstein, G., Nachtigall, L., Utian, W., Katz, M., Miller, S. et al (2005) Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 90: 5226-5233.
54. Slob, A.K., Bax, C.M., Hop, W.C.J., Rowland, D.L. and van der Werfften Bosch, J.J. (1996) Sexual arousability and the menstrual cycle. Psychoneuroendocrinology 21: 545-558.
55. Snabes, M.C. and Simes, S.M. (2009) Approved hormonal treatments for HSDD: An unmet medical need. J Sex Med 6: 1846-1849.
56. Teplin, V., Vittinghoff, E., Lin, F., Learman, L.A., Richter, H.E. and Kuppermann, M. ( 2007) Oophorectomy in premenopausal women: Health-related quality of life and sexual functioning. Obstet Gynecol 109: 347-354.
57. ter Kuile, M.M., Both, S. and van Uden, J. ( 2010) The effects of experimentally induced sad and happy mood on sexual arousal in sexually healthy women. J Sex Med 7: 1177-1184.
58. Toates, F. ( 2009) An integrative theoretical framework for understanding sexual motivation, arousal, and behaviour. J Sex Res 46: 168-193.
59. Weiss, E.L., Bowers Jr, M.B. and Mazure, C.M. ( 1999) Testosterone-patch-induced psychotic mania. Am J Psychiatry 156: 969.
60. West, S.L., D'Aloisio, A.A., Agans, R.P., Kalsbeek, W.D., Borisov, N.N. and Thorp, J.M. ( 2008) Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women. Arch Intern Med 168: 1441-1449.
61. Wierman, M.E., Basson, R., Davis, S.R., Khosla, S., Miller, K., Rosner, W. et al (2006) Androgen therapy in women: An Endocrine Society Clinical Practice Guideline. J Clin Enocrinol Metab 1: 3697-3710.
62. Wild, R.A. ( 2007) Endogenous androgens and cardiovascular risk. Menopause 14: 609-610.
63. Wylie, K. and Mimoun, S. (2009) Sexual response models in women. Maturitas 63: 112-115.